Filing Details

Accession Number:
0001209191-17-025577
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-04-05 16:06:21
Reporting Period:
2017-04-03
Filing Date:
2017-04-05
Accepted Time:
2017-04-05 16:06:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1488613 Foundation Medicine Inc. FMI Services-Medical Laboratories (8071) 271316416
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1584999 A. Vincent Miller 150 Second Street
C/O Foundation Medicine, Inc.
Cambridge MA 02141
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-03-13 1,000 $32.70 105,139 No 5 G Direct
Common Stock Disposition 2017-04-03 257 $31.96 104,882 No 4 S Direct
Common Stock Disposition 2017-04-03 1,096 $31.96 103,786 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on March 31, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person.
  2. The reporting person previously reported restricted stock units granted to the reporting person on April 9, 2014 in Table I of the Form 4/A filed on May 27, 2014. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event on March 31, 2017.
  3. Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on April 1, 2017. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person.
  4. The reporting person previously reported restricted stock units granted to the reporting person on April 1, 2016 in Table I of the Form 4 filed on April 6, 2016. As such, no adjustment to the reporting person's beneficial interest needs to be made to reflect the vesting event on April 1, 2017.